Anixa Biosciences Inc.

ANIX | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.71

+$0.01 (+0.37%)

Sep 22, 2026, 1:11 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.37%

(1D)

Rating

Updated: Aug 25, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $92.2M

1D Range

2.68 2.75

52W Range

2.32 5.46

Valuation (TTM)

PE -9

PB 6.35

EV/EBITDA -7.40

Valuation (NTM)

Forward PE N/A

Forward PEG -5.55

Price Target $5.83

Cash Flow

FCF Yield -8.0%

SBC Adj. FCF Yield -10.3%

SBC Impact -27.7%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y -150.0% | -50.0%

Dil EPS 3Y | 5Y 18.9% | 24.9%

FCF 3Y | 5Y 13.8% | -5.5%

Returns

ROA -69.1%

ROE -70.4%

ROIC -82.1%

Financial Health

Net Cash

$13.69M

Current Ratio 8.54

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Anixa Biosciences, Inc. (ANIX) is a biotechnology company dedicated to pioneering therapies and vaccines. Its core mission revolves around addressing critical, unmet medical needs, particularly within...

Sector Healthcare

Industry Biotechnology

Employees 4

IPO Date Oct 6, 1983

Website www.anixa.com

Fiscal Year November - October

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+47.60%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞